Literature DB >> 1091505

In vitro transcription of the bipolar arginine ECBH operon of Escherichia coli K 12.

H Pannekoek, R Cunin, A Boyen, N Glansdorff.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1091505     DOI： 10.1016/0014-5793(75)80872-6

Source DB:  PubMed          Journal:  FEBS Lett        ISSN： 0014-5793            Impact factor:   4.124


× No keyword cloud information.
  7 in total

1.  In vitro synthesis and repression of argininosuccinase in Escherichia coli K12; partial purification of the arginine repressor.

Authors:  N E Kelker; W K Maas; H L Yang; G Zubay
Journal:  Mol Gen Genet       Date:  1976-02-27

2.  Studies on the control region of the bipolar argECBH operon of Escherichia coli. I. Effect of regulatory mutations and IS2 insertions.

Authors:  A Boyen; D Charlier; M Crabeel; R Cunin; S Palchaudhuri; N Glansdorff
Journal:  Mol Gen Genet       Date:  1978-05-03

3.  Parameters of gene expression in the bipolar argECBH operon of E. coli K12. The question of translational control.

Authors:  R Cunin; A Boyen; P Pouwels; N Glansdorff; M Crabeel
Journal:  Mol Gen Genet       Date:  1975-09-15

4.  Transcription of Regions within the divergent argECBH operon of Escherichia coli: evidence for lack of an attenuation mechanism.

Authors:  G Beny; R Cunin; N Glansdorff; A Boyen; J Charlier; N Kelker
Journal:  J Bacteriol       Date:  1982-07       Impact factor: 3.490

5.  Regulation and coupling of argECBH mRNA and enzyme synthesis in cell extracts of Escherichia coli.

Authors:  M J Zidwick; G Keller; P Rogers
Journal:  J Bacteriol       Date:  1984-08       Impact factor: 3.490

6.  Regulation of argA operon expression in Escherichia coli K-12: cell-free synthesis of beta-galactosidase under argA control.

Authors:  N Kelker; T Eckhardt
Journal:  J Bacteriol       Date:  1977-10       Impact factor: 3.490

7.  In vitro transcription of the Escherichia coli K-12 argA, argE, and argCBH operons.

Authors:  D Sens; W Natter; E James
Journal:  J Bacteriol       Date:  1977-05       Impact factor: 3.490
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.